The use of combined LDL affinity apheresis utilizing dextran sulfate cellulose columns and hypolipidemic medications in patients with severe hypercholesterolemia to assess regression of atherosclerosis.
Jones
P H
PH
Methodist Hospital, Houston, Texas.
D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy*; D001781:Blood Component Removal / Q000379:methods*; D002482:Cellulose; D008078:Cholesterol, LDL / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D016264:Dextran Sulfate; D003911:Dextrans; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000150:complications / Q000628:therapy*; D008077:Lipoproteins, LDL / Q000097:blood*; D008148:Lovastatin / Q000627:therapeutic use; D008297:Male; D010956:Plasmapheresis; D012074:Remission Induction
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D003911:Dextrans; D008077:Lipoproteins, LDL; D002792:Cholestyramine Resin; D002482:Cellulose; D016264:Dextran Sulfate; D008148:Lovastatin